The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting

Prevalence of Incidental Pancreatic Cysts in the Adult Population on MR Imaging

(2010) Karen S Lee et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment

(2010) Yixing Jiang et al.   Biomarkers in Medicine

Cellular Vaccine Approaches

(2010) Dung T. Le et al.   CANCER JOURNAL

Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future

(2010) Shayna L Showalter et al.   Expert Opinion on Drug Delivery

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

(2010) Philip A. Philip et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

(2010) Gideon Bollag et al.   NATURE

PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells

(2010) Ruth Halaban et al.   Pigment Cell & Melanoma Research

Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing

(2010) R. J. Leary et al.   Science Translational Medicine

Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature

(2009) Edward James et al.   ANTI-CANCER DRUGS

Risk of Pancreatic Cancer in Families With Lynch Syndrome

(2009) Fay Kastrinos   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

(2009) Christine A. Iacobuzio-Donahue et al.   JOURNAL OF CLINICAL ONCOLOGY

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

(2009) Karl S. Peggs et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Sensitive digital quantification of DNA methylation in clinical samples

(2009) Meng Li et al.   NATURE BIOTECHNOLOGY

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

(2009) S. Jones et al.   SCIENCE

Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

(2009) K. P. Olive et al.   SCIENCE

Prevalence of Unsuspected Pancreatic Cysts on MDCT

(2008) Thomas A. Laffan et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status

(2008) Neil P. Desai et al.   ANTI-CANCER DRUGS

A Syngeneic Variance Library for Functional Annotation of Human Variation: Application to BRCA2

(2008) T. Hucl et al.   CANCER RESEARCH

Absence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic Cancer

(2008) J. M. Winter et al.   CLINICAL CANCER RESEARCH

DNA Methylation Alterations In Endoscopic Retrograde Cholangiopancreatography Brush Samples of Patients With Suspected Pancreaticobiliary Disease

(2008) Mansour A. Parsi et al.   Clinical Gastroenterology and Hepatology

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

(2008) Wataru Sakai et al.   NATURE

Resistance to therapy caused by intragenic deletion in BRCA2

(2008) Stacey L. Edwards et al.   NATURE

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

(2008) S. Jones et al.   SCIENCE